Related Experiment Video
Updated: Jun 19, 2026
13:18
Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Personalized pharmacotherapy in psychiatry
Pavo Filaković1, Anamarija Petek
1University Department of Psychiatry, Clinical Hospital Osijek, Osijek, Croatia. filakovic.pavo@kbo.hr
Psychiatria Danubina
|October 2, 2009
Summary
Personalized psychiatry utilizes pharmacogenomics and pharmacogenetics to tailor treatments. These advances enable individualized medication choices and dosages, improving psychiatric care.
Area of Science:
- Psychiatry
- Pharmacogenomics
- Pharmacogenetics
Background:
- Personalized medicine aims to tailor treatments to individual patient characteristics.
- Personalized psychiatry applies these principles to mental health care.
- Advances in pharmacogenomics and nanotechnology facilitate personalized psychiatric approaches.
Purpose of the Study:
- To explore the role of pharmacogenomics and pharmacogenetics in personalized psychiatry.
- To highlight the potential of genetic testing in optimizing psychopharmacological treatments.
- To discuss the implementation of personalized medicine in psychiatric practice.
Main Methods:
- Focus on genetic variability in drug metabolism, particularly involving cytochrome P450 enzymes (CYP2D6 and CYP2C19).
- Review of advancements in pharmacogenomics and nanotechnology.
- Discussion of the application of pharmacogenetic testing in routine psychiatric practice.
Main Results:
- Pharmacogenetic testing is crucial for medications metabolized by CYP2D6 and CYP2C19 due to their role in adverse and ultrafast drug metabolism.
- Personalized approaches include tailored medication selection, dosage, side-effect anticipation, and follow-up treatment.
- Pharmacogenomics and pharmacogenetics offer significant potential for personalized therapeutic strategies in psychiatry.
Conclusions:
- Pharmacogenomics and pharmacogenetics represent a significant advancement in personalized psychiatric care.
- These technologies aid in making more informed therapeutic decisions by reducing uncertainty.
- Clinical judgment remains essential for final treatment selection and management.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...